Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ac-2nal-4cpa-3pal-ser-4aph(hydroorotyl)-4aph(carbamoyl)-leu-ilys-pro-ala-nh2
2. Acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ilys-prolyl-alaninamide
3. Degarelix
4. Fe 200486
5. Fe-200486
6. Fe200486
7. Firmagon
8. Gonax
9. Uglypeptide1
1. 934016-19-0
2. Gonax
3. Firmagon
4. Ext215f4zu
5. Degarelix (as Acetate)
6. Degarelix Acetate Hydrate
7. Fe-200486
8. Degarelix Acetate (jan)
9. N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-4-[[[(4s)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-l-phenylalanyl-4-[(aminocarbonyl)amino]-d-phenylalanyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-d-alaninamide,monoacetate
10. Asp3550
11. Fe200486
12. Unii-ext215f4zu
13. Fe200486 (free Base)
14. Firmagon (tn)
15. Degarelix Monoacetate
16. Chembl2028987
17. Degarelix Acetate Anhydrous
18. Dtxsid201027699
19. Asp-3550
20. Mfcd16879085
21. Degarelix Monoacetate Anhydrous
22. Degarelix (acetate) Pound>>fe 200486
23. Degarelix Acetate(214766-78-6 Free Base)
24. D09400
25. Q27277419
26. D-alaninamide, N-acetyl-3-(naphtalen-2-yl)-d-alanyl-4-chloro-d-phenylalanyl-3-(pyridin-3-yl)-d-alanyl-l-seryl-4-((((4s)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-l-phenylalanyl-4-(carbamoylamino)-d-phenylalanyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-, Acetate (1:1)
Molecular Weight | 1692.3 g/mol |
---|---|
Molecular Formula | C84H107ClN18O18 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 41 |
Exact Mass | 1690.7699263 g/mol |
Monoisotopic Mass | 1690.7699263 g/mol |
Topological Polar Surface Area | 550 Ų |
Heavy Atom Count | 121 |
Formal Charge | 0 |
Complexity | 3420 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 11 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
FIRMAGON is a gonadotrophin releasing hormone (GnRH) antagonist indicated:
- for treatment of adult male patients with advanced hormone-dependent prostate cancer .
- for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
- as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer .
L02BX02
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
99
PharmaCompass offers a list of Degarelix Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Degarelix Acetate manufacturer or Degarelix Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Degarelix Acetate manufacturer or Degarelix Acetate supplier.
PharmaCompass also assists you with knowing the Degarelix Acetate API Price utilized in the formulation of products. Degarelix Acetate API Price is not always fixed or binding as the Degarelix Acetate Price is obtained through a variety of data sources. The Degarelix Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A FIRMAGON manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FIRMAGON, including repackagers and relabelers. The FDA regulates FIRMAGON manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FIRMAGON API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of FIRMAGON manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A FIRMAGON supplier is an individual or a company that provides FIRMAGON active pharmaceutical ingredient (API) or FIRMAGON finished formulations upon request. The FIRMAGON suppliers may include FIRMAGON API manufacturers, exporters, distributors and traders.
click here to find a list of FIRMAGON suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A FIRMAGON DMF (Drug Master File) is a document detailing the whole manufacturing process of FIRMAGON active pharmaceutical ingredient (API) in detail. Different forms of FIRMAGON DMFs exist exist since differing nations have different regulations, such as FIRMAGON USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A FIRMAGON DMF submitted to regulatory agencies in the US is known as a USDMF. FIRMAGON USDMF includes data on FIRMAGON's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The FIRMAGON USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of FIRMAGON suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a FIRMAGON Drug Master File in Korea (FIRMAGON KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of FIRMAGON. The MFDS reviews the FIRMAGON KDMF as part of the drug registration process and uses the information provided in the FIRMAGON KDMF to evaluate the safety and efficacy of the drug.
After submitting a FIRMAGON KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their FIRMAGON API can apply through the Korea Drug Master File (KDMF).
click here to find a list of FIRMAGON suppliers with KDMF on PharmaCompass.
A FIRMAGON written confirmation (FIRMAGON WC) is an official document issued by a regulatory agency to a FIRMAGON manufacturer, verifying that the manufacturing facility of a FIRMAGON active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting FIRMAGON APIs or FIRMAGON finished pharmaceutical products to another nation, regulatory agencies frequently require a FIRMAGON WC (written confirmation) as part of the regulatory process.
click here to find a list of FIRMAGON suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FIRMAGON as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for FIRMAGON API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture FIRMAGON as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain FIRMAGON and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FIRMAGON NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of FIRMAGON suppliers with NDC on PharmaCompass.
FIRMAGON Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FIRMAGON GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FIRMAGON GMP manufacturer or FIRMAGON GMP API supplier for your needs.
A FIRMAGON CoA (Certificate of Analysis) is a formal document that attests to FIRMAGON's compliance with FIRMAGON specifications and serves as a tool for batch-level quality control.
FIRMAGON CoA mostly includes findings from lab analyses of a specific batch. For each FIRMAGON CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FIRMAGON may be tested according to a variety of international standards, such as European Pharmacopoeia (FIRMAGON EP), FIRMAGON JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FIRMAGON USP).